BC Platforms, a world leader in providing powerful genomic data management and analysis solutions, today announced the appointment of Chief Commercial Officer (CCO), North America, Weston Fox to its Management Team. Mr. Fox, who has extensive experience and networks in Healthcare and Life Science, will work closely with the company’s established commercial team, to lead the business […]
WASHINGTON — Danaher Corporation (NYSE: DHR) announced today that Jose-Carlos (“JC”) Gutierrez-Ramos has been named Senior Vice President and Chief Scientific Officer for Danaher. In this role, Dr. Gutierrez-Ramos will have responsibility for helping define Danaher’s science and technology strategy across the organization, including facilitating innovation and further development of scientific and technology talent. With […]
We are delighted to announce the appointment of Mr Antonin Duval as CEO of Techcomp Lab Products which includes Dynamica, Edinburgh Sensors, Precisa and Froilabo. Antonin will be overseeing the growth of these brands with a commercial and product development focus. Antonin joins us from Bertin Technologies, where he enjoyed a great deal of success […]
– – Patrick Kaltenbach to Become CEO – –– – Olivier Filliol Remains Member of Board of Directors – – COLUMBUS, Ohio — Mettler-Toledo International Inc. (NYSE: MTD) today announced that Olivier Filliol, after 13 years as CEO, has chosen to step down and the Board of Directors has agreed on a CEO transition. Patrick […]
CAMBRIDGE, Mass. — Ultivue announces the addition of two new executive team members in order to help strengthen its position as a leading assay development solutions provider for multiplex biomarker analysis. Keith Wharton MD PhD has recently joined Ultivue in the role of Vice President, Medical Director, and James (Bud) Drummey has joined as Vice […]
SOUTH SAN FRANCISCO, Calif. — Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the appointment of Dr. Ana K. Stankovic, MD, PhD, MSPH, to the company’s Board of Directors. Dr. Stankovic is a seasoned leader with more than 30 years of research and […]
Dr. Acheson, Former Chief Medical Officer for USDA and FDA, will advise the company as it develops advanced testing technology for the food safety industry SCOTTSDALE, Ariz. — PathogenDx, Inc., an Arizona based technology company which has developed a multiplexed microarray DNA-based pathogen testing platform, announced today that Dr. David Acheson will join the company as a strategic advisor. As part […]
WASHINGTON — Danaher Corporation (NYSE: DHR) announced today that effective January 1, 2021, its Board of Directors has appointed Jennifer L. Honeycutt to the position of Executive Vice President of Danaher Corporation, with responsibility for the Company’s Beckman Coulter Life Sciences, Integrated DNA Technologies (IDT), Leica Microsystems, Molecular Devices, Pall, Phenomenex, and SCIEX businesses. With this appointment, Ms. […]
Company announces $24 million Series A financing and appoints Jason T. Gammack as CEO to accelerate development and commercialization of Molecular CartographyTM platform MONHEIM AM RHEIN, Germany – Resolve Biosciences, the pioneer in Molecular Cartography™, today announced the completion of a $24 million Series A financing round and the appointment of Co-founder Jason T. Gammack […]
Dr. Paik’s deep expertise in microfluidics and product development to be applied in advancing Molecular Assemblies’ breakthrough enzymatic DNA synthesis technology into a commercial platform SAN DIEGO — Molecular Assemblies, Inc., a pioneer in the field of enzymatic DNA synthesis, today announced the appointment of Phil Paik, Ph.D., as Vice President, Platform Development. Dr. Paik […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
